Can Wu

906 total citations
15 papers, 710 citations indexed

About

Can Wu is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, Can Wu has authored 15 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Nephrology. Recurrent topics in Can Wu's work include MicroRNA in disease regulation (5 papers), Chronic Kidney Disease and Diabetes (4 papers) and Parathyroid Disorders and Treatments (3 papers). Can Wu is often cited by papers focused on MicroRNA in disease regulation (5 papers), Chronic Kidney Disease and Diabetes (4 papers) and Parathyroid Disorders and Treatments (3 papers). Can Wu collaborates with scholars based in China. Can Wu's co-authors include Qiuyue Wang, Chuan Lv, Xiaoyu Ma, Ying Shao, Huiwen Ren, Ying Shao, Yuehong Zhou, Fenqin Chen, Lei Sha and Guan Wang and has published in prestigious journals such as Molecular and Cellular Endocrinology, Diabetes Research and Clinical Practice and Diabetes/Metabolism Research and Reviews.

In The Last Decade

Can Wu

15 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Can Wu China	13	333	195	172	121	89	15	710
Jun Feng China	18	363 1.1×	69 0.4×	243 1.4×	108 0.9×	74 0.8×	24	716
Yu Ishimoto Japan	10	346 1.0×	73 0.4×	274 1.6×	141 1.2×	100 1.1×	21	880
Guijun Qin China	19	527 1.6×	276 1.4×	167 1.0×	107 0.9×	83 0.9×	49	936
Yanqin Fan China	11	340 1.0×	134 0.7×	82 0.5×	100 0.8×	51 0.6×	18	628
Yusuke Sakamaki Japan	14	409 1.2×	57 0.3×	312 1.8×	171 1.4×	91 1.0×	23	972
Zhiyao Zhu China	11	432 1.3×	239 1.2×	198 1.2×	62 0.5×	55 0.6×	23	723
Yunpeng Chang China	10	300 0.9×	93 0.5×	187 1.1×	122 1.0×	90 1.0×	14	647
Xinli Xu China	9	246 0.7×	51 0.3×	322 1.9×	54 0.4×	82 0.9×	12	690
Zhen Sun China	17	319 1.0×	80 0.4×	93 0.5×	170 1.4×	101 1.1×	41	812
Xiaoyan Hou China	10	269 0.8×	122 0.6×	71 0.4×	188 1.6×	64 0.7×	15	483

Countries citing papers authored by Can Wu

Since Specialization

Citations

This map shows the geographic impact of Can Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Wu more than expected).

Fields of papers citing papers by Can Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Wu. The network helps show where Can Wu may publish in the future.

Co-authorship network of co-authors of Can Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Can Wu. A scholar is included among the top collaborators of Can Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can Wu. Can Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lv, Chuan, Can Wu, Yan Zhang, et al.. (2022). Sintilimab-Induced Diabetic Ketoacidosis in a Patient with Radiation and Multichemorefractory Penile Cancer: A Case Report and Literature Review. Current Oncology. 29(11). 7987–7993. 1 indexed citations

Ren, Huiwen, Ying Shao, Can Wu, et al.. (2020). VASH-1 Regulates Oxidative Stress and Fibrosis in Diabetic Kidney Disease via SIRT1/HIF1α and TGFβ1/Smad3 Signaling Pathways. Frontiers in Molecular Biosciences. 7. 137–137. 20 indexed citations

Ren, Huiwen, et al.. (2020). Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study. Frontiers of Medicine. 14(5). 642–650. 13 indexed citations

Ren, Huiwen, Ying Shao, Can Wu, et al.. (2019). Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK/SIRT1-FoxO1 pathway. Molecular and Cellular Endocrinology. 500. 110628–110628. 244 indexed citations

Wu, Can, et al.. (2018). Klotho Restraining Egr1/TLR4/mTOR Axis to Reducing the Expression of Fibrosis and Inflammatory Cytokines in High Glucose Cultured Rat Mesangial Cells. Experimental and Clinical Endocrinology & Diabetes. 127(9). 630–640. 30 indexed citations

Wu, Can, et al.. (2018). Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose. International Journal of Endocrinology. 2018. 1–15. 16 indexed citations

Shao, Ying, Huiwen Ren, Chuan Lv, et al.. (2016). Changes of serum Mir-217 and the correlation with the severity in type 2 diabetes patients with different stages of diabetic kidney disease. Endocrine. 55(1). 130–138. 49 indexed citations

Ren, Huiwen, et al.. (2016). Expression levels of serum vasohibin-1 in type 2 diabetes mellitus patients with different excretion rates of urinary albumin and its clinical significance. Zhonghua neifenmi daixie zazhi. 32(11). 647–651. 1 indexed citations

Ma, Xiaoyu, et al.. (2016). The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio. Journal of Diabetes Research. 2016. 1–6. 47 indexed citations

10.

Shao, Ying, Chuan Lv, Can Wu, Yuehong Zhou, & Qiuyue Wang. (2016). Mir‐217 promotes inflammation and fibrosis in high glucose cultured rat glomerular mesangial cells via Sirt1/HIF‐1α signaling pathway. Diabetes/Metabolism Research and Reviews. 32(6). 534–543. 86 indexed citations

11.

Wu, Can, Chuan Lv, Fenqin Chen, et al.. (2015). The function of miR-199a-5p/Klotho regulating TLR4/NF-κB p65/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism. Molecular and Cellular Endocrinology. 417. 84–93. 44 indexed citations

12.

Lv, Chuan, et al.. (2015). The changes in miR‐130b levels in human serum and the correlation with the severity of diabetic nephropathy. Diabetes/Metabolism Research and Reviews. 31(7). 717–724. 57 indexed citations

13.

Zhou, Yuehong, Chuan Lv, Can Wu, et al.. (2014). Suppressor of cytokine signaling (SOCS) 2 attenuates renal lesions in rats with diabetic nephropathy. Acta Histochemica. 116(5). 981–988. 24 indexed citations

14.

Lv, Chuan, Can Wu, Yuehong Zhou, et al.. (2014). Alpha Lipoic Acid Modulated High Glucose-Induced Rat Mesangial Cell Dysfunction via mTOR/p70S6K/4E-BP1 Pathway. International Journal of Endocrinology. 2014. 1–14. 16 indexed citations

15.

Wu, Can, Qiuyue Wang, Chuan Lv, et al.. (2014). The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. Diabetes Research and Clinical Practice. 106(2). 343–350. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact